论文信息 - Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2‐Positive Locally Recurrent or Metastatic Breast Cancer - 字舞流文

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2‐Positive Locally Recurrent or Metastatic Breast Cancer

H. Wildiers | A. Stopeck | G. Jerusalem | F. Dalenc | M. Kemeny | P. Kaufman | Benjamin Wu | N. Nanayakkara | A. Gonçalves | G. Freyer | N. Vrindavanam | C. A. Pickett